Pharmacological stimulation for IVF in China typically costs from $1,800 to $4,200. The total price depends on medication origin and dosage requirements. In the US, similar procedures cost around $5,000 on average. China offers savings of around 40%. Main medical hubs for fertility include Shenzhen, Beijing, and Shanghai.
Bookimed Expert Insight: Choosing a facility in Shenzhen like DHC IVF Shenzhen Deep Health Care ensures high standards. This clinic is accredited by the Joint Commission International (JCI). It also holds ISO quality management systems certifications. While domestic drugs save money, international-standard clinics provide personalized plans. These plans often optimize drug usage for better results.
| China | Turkey | Austria | |
| Pharmacological stimulation for IVF | ≈ $1,800 | from $700 | ≈ $4,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Pharmacological stimulation for IVF upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pharmacological stimulation for IVF and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pharmacological stimulation for IVF journey.
Day 1 - Arrival
Day 2 - Pre-operation
Day 3 - Day 14 - Pharmacological Stimulation
Day 15 - Egg Retrieval
Day 16 - Day 20 - Embryo Development
Day 21 - Embryo Transfer
Day 22 - Day 28 - Post-operation
Week 5 and onwards - Rehabilitation
Each case is individual and the plan may vary based on the patient’s health condition and response to the treatment.
Dr. Wasin Naknam is a reproductive medicine specialist at DHC IVF Shenzhen. He holds Thai board certifications in infertility and assisted reproductive technology. Dr. Naknam earned a master’s degree in biotechnology of human reproduction from the University of Valencia. He presented original research at the ESHRE 2020 annual meeting.
This involves using medications to stimulate the ovaries to produce multiple eggs for retrieval during fertility treatment.